Company Filing History:
1 out of 28 
1 out of 52 
1 out of 318 
Years Active: 2025
Title: Slimane Allali: Innovator in Sickle Cell Disease Treatment
Introduction
Slimane Allali is a notable inventor based in Meudon, France. He has made significant contributions to the field of medicine, particularly in the treatment of sickle cell disease. His innovative work has led to the development of a patent that addresses critical health challenges faced by patients.
Latest Patents
Slimane Allali holds a patent for Masitinib, which is a 2-aminoarylthiazole derivative or a pharmaceutically acceptable salt or solvate thereof. This invention is specifically aimed at treating sickle cell disease in patients who are in need of such treatment. Additionally, the patent covers the use of Masitinib for the prevention and/or treatment of acute chest syndrome (ACS) in sickle cell disease patients.
Career Highlights
Throughout his career, Slimane Allali has worked with prominent organizations such as Ab Science and Université Paris Cité. His experience in these institutions has allowed him to further his research and contribute to advancements in medical treatments.
Collaborations
Slimane has collaborated with esteemed colleagues, including Alain Moussy and Jean-Pierre Kinet. These partnerships have enriched his work and expanded the impact of his innovations in the medical field.
Conclusion
Slimane Allali's contributions to the treatment of sickle cell disease through his patent for Masitinib highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and patient care.